Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study.

IF 2.1 4区医学 Q3 OBSTETRICS & GYNECOLOGY Hypertension in Pregnancy Pub Date : 2021-08-01 Epub Date: 2021-08-24 DOI:10.1080/10641955.2021.1965621

Michael Baracy, Fareeza Afzal, Susanna M Szpunar, Makenzie Tremp, Karlee Grace, Marina Liovas, Muhammad Faisal Aslam

{"title":"Coronavirus disease 2019 (COVID-19) and the risk of hypertensive disorders of pregnancy: a retrospective cohort study.","authors":"Michael Baracy, Fareeza Afzal, Susanna M Szpunar, Makenzie Tremp, Karlee Grace, Marina Liovas, Muhammad Faisal Aslam","doi":"10.1080/10641955.2021.1965621","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate of COVID-19 disease in pregnant women and its association with hypertensive disorders of pregnancy.Design: Retrospective Cohort StudySetting: Multicenter study from a large metropolitan hospital systemMethods: Patients who tested positive for COVID-19 during their pregnancy and delivered were compared to the three subsequent deliveries of patients who tested negative (controls). We evaluated the impact of COVID-19 on the development of hypertensive disorders of pregnancy.Results: Compared with pregnancies negative for SARs-CoV-2 infection, maternal SARs-CoV-2 infection was associated with an increased risk for hypertensive disorders of pregnancy (OR 3.68, 95% CI 1.67 - 8.10).Tweetable AbstractPatients who test positive for COVID-19 during their pregnancy are at increased risk of developing a hypertensive disorder of pregnancy. Earlier SARs-CoV-2 infection results in an increased risk of developing a hypertensive disorder.","PeriodicalId":13054,"journal":{"name":"Hypertension in Pregnancy","volume":"40 3","pages":"226-235"},"PeriodicalIF":2.1000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension in Pregnancy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10641955.2021.1965621","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 6

Abstract

Objective: To evaluate of COVID-19 disease in pregnant women and its association with hypertensive disorders of pregnancy.Design: Retrospective Cohort StudySetting: Multicenter study from a large metropolitan hospital systemMethods: Patients who tested positive for COVID-19 during their pregnancy and delivered were compared to the three subsequent deliveries of patients who tested negative (controls). We evaluated the impact of COVID-19 on the development of hypertensive disorders of pregnancy.Results: Compared with pregnancies negative for SARs-CoV-2 infection, maternal SARs-CoV-2 infection was associated with an increased risk for hypertensive disorders of pregnancy (OR 3.68, 95% CI 1.67 - 8.10).Tweetable AbstractPatients who test positive for COVID-19 during their pregnancy are at increased risk of developing a hypertensive disorder of pregnancy. Earlier SARs-CoV-2 infection results in an increased risk of developing a hypertensive disorder.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

冠状病毒病2019 (COVID-19)与妊娠高血压疾病的风险:一项回顾性队列研究

目的:探讨妊娠妇女COVID-19疾病及其与妊娠期高血压疾病的关系。设计:回顾性队列研究设置:来自大型大都市医院系统的多中心研究方法:将怀孕和分娩期间COVID-19检测呈阳性的患者与随后三次分娩检测呈阴性的患者(对照组)进行比较。我们评估了COVID-19对妊娠期高血压疾病发展的影响。结果:与未感染SARs-CoV-2的孕妇相比，母体感染SARs-CoV-2与妊娠期高血压疾病的风险增加相关(OR 3.68, 95% CI 1.67 - 8.10)。摘要怀孕期间COVID-19检测呈阳性的患者患妊娠期高血压疾病的风险增加。早期感染SARs-CoV-2会导致患高血压疾病的风险增加。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Hypertension in Pregnancy 医学-妇产科学

CiteScore

3.40

自引率

0.00%

发文量

审稿时长

6 months

期刊介绍： Hypertension in Pregnancy is a refereed journal in the English language which publishes data pertaining to human and animal hypertension during gestation. Contributions concerning physiology of circulatory control, pathophysiology, methodology, therapy or any other material relevant to the relationship between elevated blood pressure and pregnancy are acceptable. Published material includes original articles, clinical trials, solicited and unsolicited reviews, editorials, letters, and other material deemed pertinent by the editors.